Venetoclax-based combination therapy as a bridge to allogeneic hematopoietic cell transplant in children with relapsed/refractory AML

被引：0
|
作者：
Pfeiffer, Thomas [1 ]
Li, Ying [1 ]
Karol, Seth E.
Rubnitz, Jeffrey E. [2 ]
Epperly, Rebecca [1 ]
Madden, Renee [1 ]
Mamcarz, Ewelina [1 ]
Obeng, Esther A. [1 ]
Qudeimat, Amr [1 ]
Sharma, Akshay [1 ]
Srinivasan, Ashok [1 ]
Suliman, Ali [1 ]
Talleur, Aimee C. [1 ]
Velasquez, Mireya Paulina [1 ]
Gottschalk, Stephen [1 ]
Triplett, Brandon M. [1 ]
Naik, Swati [1 ]
机构：
[1] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Theraphy, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study
    Unglaub, Julia M.
    Schlenk, Richard F.
    Hanoun, Maher
    Reinhardt, H. Christian
    Middeke, Jan Moritz
    Schaefer-Eckart, Kerstin
    Steffen, Bjoern
    Krause, Stefan W.
    Schliemann, Christoph
    Kaufmann, Martin
    Haenel, Mathias
    Jost, Edgar
    Crysandt, Martina
    Fransecky, Lars
    Kraus, Sabrina
    Einsele, Hermann
    Niemann, Dirk
    Neubauer, Andreas
    Seggewiss-Bernhardt, Ruth
    Scholl, Sebastian
    Klein, Stefan
    Schmid, Christoph
    Schaich, Markus
    Platzbecker, Uwe
    Baldus, Claudia D.
    Bornhaeuser, Martin
    Serve, Hubert
    Rollig, Christoph
    Kramer, Michael
    Katelari, Elena
    Janssen, Maike
    Pabst, Caroline
    Luft, Thomas
    Dreger, Peter
    Mueller-Tidow, Carsten
    Sauer, Tim
    BLOOD, 2021, 138
  • [22] Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant
    McEwan, Ashley
    Pitiyarachchi, Omali
    Viiala, Nicholas
    HEMASPHERE, 2020, 4 (03):
  • [23] Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant
    Rahmat, Leena T.
    Nguyen, Anna
    Abdulhaq, Haifaa
    Prakash, Sonam
    Logan, Aaron C.
    Mannis, Gabriel N.
    CASE REPORTS IN HEMATOLOGY, 2018, 2018
  • [24] Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?
    Tarantini, Francesco
    Cumbo, Cosimo
    Anelli, Luisa
    Zagaria, Antonella
    Coccaro, Nicoletta
    Tota, Giuseppina
    Minervini, Angela
    Minervini, Crescenzio Francesco
    Parciante, Elisa
    Conserva, Maria Rosa
    Redavid, Immacolata
    Specchia, Giorgina
    Musto, Pellegrino
    Albano, Francesco
    LEUKEMIA & LYMPHOMA, 2024, 65 (12) : 1777 - 1788
  • [25] Venetoclax-based regimens in combination with trametinib for RAS-mutated relapsed or refractory myeloid malignancies
    Lukas Kevlicius
    Ruta Cepulyte
    Dominika Vasilevska
    Laimonas Griskevicius
    Andrius Zucenka
    Bone Marrow Transplantation, 2022, 57 : 1034 - 1037
  • [26] Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia
    Canaani, Jonathan
    Frisch, Avraham
    Pollyea, Daniel A.
    Schwartz, Marc
    Aumann, Shlomzion
    Ganzel, Chezi
    Haran, Arnon
    Even-Zohar, Noa Gross
    Shaulov, Adir
    Vainstein, Vladimir
    Moshe, Yakir
    Ofran, Yishai
    Wolach, Ofir
    Nachmias, Boaz
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 365 - 372
  • [27] Venetoclax-based therapy in treatment-naive and relapsed/refractory acute myeloid leukemia
    Ravindra, Aditya
    Acharya, Luna
    Loeffler, Bradley
    Bell, Sarah L.
    Sutamtewagul, Grerk
    Dhakal, Prajwal
    CANCER RESEARCH, 2023, 83 (07)
  • [28] A Retrospective Study of Venetoclax-Based Salvage Regimen As a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) in High-Risk Acute Myeloid Leukemia (AML) Patients
    Sandhu, Karamjeet S.
    Aldoss, Ibrahim
    Yang, Dongyun
    Mokhtari, Sally
    Mei, Matthew
    Aribi, Ahmed
    Ali, Haris
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Khaled, Samer K.
    Budde, Lihua E.
    Sun, Weili
    O'Donnell, Margaret
    Snyder, David S.
    Forman, Stephen J.
    Stein, Anthony S.
    Marcucci, Guido
    Nakamura, Ryotaro
    Pullarkat, Vinod
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [29] Venetoclax-based regimens in combination with trametinib for RAS-mutated relapsed or refractory myeloid malignancies
    Kevlicius, Lukas
    Cepulyte, Ruta
    Vasilevska, Dominika
    Griskevicius, Laimonas
    Zucenka, Andrius
    BONE MARROW TRANSPLANTATION, 2022, 57 (06) : 1034 - 1037
  • [30] Use of FLT3 Inhibitors to Bridge Relapsed/Refractory AML Patients to an Allogeneic Stem Cell Transplant
    Canaani, Jonathan
    Frey, Noelle V.
    Gill, Saar
    Luskin, Marlise R.
    Hexner, Elizabeth O.
    Loren, Alison W.
    Luger, Selina M.
    Mangan, James
    Porter, David L.
    Perl, Alexander E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S199 - S200
12345